Grace Therapeutics (GRCE) Consolidated Net Income (2011 - 2026)
Grace Therapeutics (GRCE) posted Consolidated Net Income of -$2.13 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$938,000 a year earlier.
Grace Therapeutics (GRCE) Consolidated Net Income (2011 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Consolidated Net Income at Grace Therapeutics was -$21.41 million; for FY2026 (ended Mar 31, 2026), it was -$7.79 million.
- In prior fiscal years, Grace Therapeutics' Consolidated Net Income was -$9.57 million in FY2025, -$12.85 million in FY2024, -$42.43 million in FY2023 and -$9.82 million in FY2022.
- Quarterly Consolidated Net Income has run from a low of -$29.09 million in fiscal Q4 2023 to a high of $636,000 in fiscal Q4 2025 over five years.
- According to Business Quant data, Consolidated Net Income for the three prior fiscal quarters was -$15.79 million (Q1 2027), -$1.18 million (Q4 2026) and -$2.32 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | -2.13 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.13 Mn |
| Jun 30, 2026 | -15.79 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | 636,000.00 |
| Dec 31, 2024 | -4.16 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -2.62 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -3.27 Mn |
| Jun 30, 2023 | -4.02 Mn |
| Mar 31, 2023 | -29.09 Mn |
| Dec 31, 2022 | -3.89 Mn |
| Sep 30, 2022 | -4.93 Mn |
| Jun 30, 2022 | -4.52 Mn |
| Mar 31, 2022 | -3.90 Mn |
| Dec 31, 2021 | -3.78 Mn |
Grace Therapeutics Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();